![Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage | Molecular Pharmaceutics Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.6b00445/asset/images/large/mp-2016-00445e_0009.jpeg)
Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage | Molecular Pharmaceutics
Abstracts from the 2015 European Association for Vision and Eye Research Conference: Acta Ophthalmologica: Vol 93, No S255
![Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation - ScienceDirect Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928493118332594-ga1.jpg)
Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation - ScienceDirect
![Secondary glaucoma: Toward interventions based on molecular underpinnings - Mueller - WIREs Mechanisms of Disease - Wiley Online Library Secondary glaucoma: Toward interventions based on molecular underpinnings - Mueller - WIREs Mechanisms of Disease - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/88a3685f-f121-4bb3-b4f1-e2bef23eb3d5/wsbm1628-toc-0001-m.jpg)
Secondary glaucoma: Toward interventions based on molecular underpinnings - Mueller - WIREs Mechanisms of Disease - Wiley Online Library
![CAS No : 155206-00-1| Product Name : Bimatoprost - API| Chemical Name : Bimatoprost | Pharmaffiliates CAS No : 155206-00-1| Product Name : Bimatoprost - API| Chemical Name : Bimatoprost | Pharmaffiliates](https://www.pharmaffiliates.com/pimages/PA0272000.jpg)
CAS No : 155206-00-1| Product Name : Bimatoprost - API| Chemical Name : Bimatoprost | Pharmaffiliates
![Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface - Bitton - 2017 - Clinical and Experimental Optometry - Wiley Online Library Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface - Bitton - 2017 - Clinical and Experimental Optometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aef87f29-5fed-44e8-9b00-dcc28e6c5361/cxo12507-fig-0001-m.jpg)
Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface - Bitton - 2017 - Clinical and Experimental Optometry - Wiley Online Library
![Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats | Communications Biology Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-022-04134-w/MediaObjects/42003_2022_4134_Fig1_HTML.png)
Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats | Communications Biology
![Pharmaceutics | Free Full-Text | Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases Pharmaceutics | Free Full-Text | Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-01746/article_deploy/html/images/pharmaceutics-15-01746-g002.png?1686909299)
Pharmaceutics | Free Full-Text | Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases
![Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities | Journal of Medicinal Chemistry Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00600/asset/images/large/jm2c00600_0008.jpeg)
Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities | Journal of Medicinal Chemistry
Public Assessment Report Scientific discussion Bimato-Vision 0.1 mg/ml, eye drops, solution (bimatoprost) NL/H/3025/001/DC Date
![Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface - Bitton - 2017 - Clinical and Experimental Optometry - Wiley Online Library Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface - Bitton - 2017 - Clinical and Experimental Optometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8032578-87dc-4ad6-80f8-ce0b9655a2b7/cxo12507-fig-0004-m.jpg)